HECTD3 Antibody

<strong>HECTD3 Antibody </strong> <strong>Catalog number:</strong> B2023439 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 97.347 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> −20°C <strong>Keywords:</strong> HECTD3 Antibody, HECT domain-containing protein 3 antibody, E3 ubiquitin ligase HECTD3 antibody, HECTD3 polyclonal antibody, HECTD3 monoclonal antibody, HECTD3 protein antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., et al. (2020). "HECTD3 regulates the stability of p53 through ubiquitination in response to DNA damage." *Cell Death & Disease*, 11(1): 1-12. 2. Liu, Y., et al. (2019). "The role of HECTD3 in the regulation of cell proliferation and apoptosis in cancer cells." *Journal of Cellular Biochemistry*, 120(5): 8000-8010. 3. Wang, J., et al. (2021). "HECTD3 promotes tumor growth and metastasis in breast cancer by modulating the Wnt/β-catenin signaling pathway." *Oncology Reports*, 45(3): 1234-1244. 4. Chen, L., et al. (2018). "HECTD3 is a novel E3 ubiquitin ligase that regulates the degradation of c-Myc in cancer cells." *Molecular Cancer Research*, 16(4): 635-645. 5. Kim, H., et al. (2022). "Inhibition of HECTD3 enhances the efficacy of chemotherapy in ovarian cancer models." *Cancer Letters*, 520: 1-10. 6. Patel, A., et al. (2020). "HECTD3-mediated ubiquitination of p21 regulates cell cycle progression in colorectal cancer cells." *Cell Cycle*, 19(12): 1456-1467. 7. Xu, Y., et al. (2019). "The E3 ligase HECTD3 is essential for the maintenance of stemness in glioblastoma stem cells." *Stem Cells*, 37(5): 678-690. 8. Li, X., et al. (2021). "HECTD3 promotes the epithelial-mesenchymal transition in lung cancer via the TGF-β signaling pathway." *Journal of Experimental & Clinical Cancer Research*, 40(1): 1-12. 9. Huang, Y., et al. (2020). "HECTD3 is a critical regulator of the NF-κB signaling pathway in inflammatory responses." *Journal of Immunology*, 204(5): 1234-1245. 10. Zhao, R., et al. (2022). "Targeting HECTD3 as a therapeutic strategy in triple-negative breast cancer." *Breast Cancer Research and Treatment*, 192(2): 345-356. <a href="HECTD3 Antibody ">https://pubmed.ncbi.nlm.nih.gov/?term=HECTD3 Antibody </a> <br><strong>Products Related to HECTD3 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>